Literature DB >> 12235069

Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.

P V Sherwood1, J I D Wibawa, J C Atherton, N Jordan, D Jenkins, D A Barrett, P N Shaw, R C Spiller.   

Abstract

BACKGROUND AND AIMS: The success of Helicobacter pylori eradication regimens depends on gastric pH, inflammation, and mucus thickness. Our aim was to investigate the effects of acid secretion, inflammation, and mucolysis on gastric antibiotic transfer. SUBJECTS AND METHODS: A total of 134 anaesthetised rats were given metronidazole, amoxicillin, or clarithromycin intravenously and gastric contents were aspirated via an indwelling cannula. Acid secretion was controlled by either omeprazole or pentagastrin while gastritis was induced by infection with H pylori or dosing with iodoacetamide. Mucolysis was achieved by instilling pronase into the gastric lumen.
RESULTS: Metronidazole transfer increased with acid secretion and fell with omeprazole, independently of gastric pH. Clarithromycin was also transferred with acid but was then rapidly degraded. Omeprazole prevented this degradation, raising gastric luminal concentrations. Omeprazole did not alter amoxicillin transfer. Gastritis induced by H pylori did not alter gastric transfer of metronidazole and amoxicillin but that of clarithromycin was increased by 23%. However, gastritis induced by iodoacetamide reduced clarithromycin transfer without any effect on metronidazole or amoxicillin transfer. Pronase treatment increased amoxicillin transfer fourfold and metronidazole by 66% but reduced clarithromycin transfer by 35%.
CONCLUSIONS: Metronidazole and clarithromycin are predominantly transferred with gastric acid rather than by an acid trapping mechanism. Pronase increases the appearance of amoxicillin and metronidazole in gastric secretions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235069      PMCID: PMC1773392          DOI: 10.1136/gut.51.4.490

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.

Authors:  A F Goddard; M J Jessa; D A Barrett; P N Shaw; J P Idström; C Cederberg; R C Spiller
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

2.  Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection.

Authors:  S Y Chu; L T Sennello; R C Sonders
Journal:  J Chromatogr       Date:  1991-11-15

3.  Rapid and selective high-performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice.

Authors:  M J Jessa; D A Barrett; P N Shaw; R C Spiller
Journal:  J Chromatogr B Biomed Appl       Date:  1996-03-03

4.  Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges.

Authors:  J S Bakken; J N Bruun; P Gaustad; T C Tasker
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

5.  Determination of ampicillin, amoxicillin, cephalexin, and cephradine in plasma by high-performance liquid chromatography using fluorometric detection.

Authors:  K Miyazaki; K Ohtani; K Sunada; T Arita
Journal:  J Chromatogr       Date:  1983-09-09

6.  The adherent gastric antral and duodenal mucus gel layer thins with advancing age in subjects infected with Helicobacter pylori.

Authors:  J L Newton; N Jordan; J Pearson; G V Williams; A Allen; O F James
Journal:  Gerontology       Date:  2000 May-Jun       Impact factor: 5.140

7.  Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo.

Authors:  N Kalia; K D Bardhan; M W Reed; S Jacob; N J Brown
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

8.  Patient factors affecting Helicobacter pylori eradication with triple therapy.

Authors:  A F Cutler; T T Schubert
Journal:  Am J Gastroenterol       Date:  1993-04       Impact factor: 10.864

9.  Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells.

Authors:  F Megraud; H Lamouliatte; L Boyanova
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

10.  Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.

Authors:  J Labenz; F Leverkus; G Börsch
Journal:  Scand J Gastroenterol       Date:  1994-12       Impact factor: 2.423

View more
  7 in total

1.  Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.

Authors:  Kai Y Liu; Fang C Du; Qiang Fu; Wei J Zhang; Hong W Sun; Yi Zhang; Le L Gan; Zhi Y Yue; Quan M Zou; Gang Guo
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

Authors:  Luís Eduardo S Fontes; Ana Luiza C Martimbianco; Carolina Zanin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

3.  Transfer and distribution of amoxicillin in the rat gastric mucosa and gastric juice and the effects of rabeprazole.

Authors:  Hai-lun Zheng; Yong-mei Hu; Jun-jun Bao; Jian-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2010-03-22       Impact factor: 6.150

4.  An Additive Effect of Oral N-Acetyl Cysteine on Eradication of Helicobacter pylori.

Authors:  Seyed Mohammad-Taghi Hamidian; Najmeh-Sadat Aletaha; Reza Taslimi; Mohammad Montazeri
Journal:  J Pathog       Date:  2015-09-02

5.  Effect of rabeprazole on the transport and distribution of levofloxacin in rat stomachs.

Authors:  Junjun Bao; Yongmei Hu; Qiao Mei; Hailun Zhen; Jianming Xu
Journal:  Exp Ther Med       Date:  2014-10-17       Impact factor: 2.447

6.  Additive Effect of Pronase on the Eradication Rate of First-Line Therapy for Helicobacter pylori Infection.

Authors:  Chang Seok Bang; Yeon Soo Kim; Sang Hyun Park; Jin Bong Kim; Gwang Ho Baik; Ki Tae Suk; Jai Hoon Yoon; Dong Joon Kim
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

7.  In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains.

Authors:  Paweł Krzyżek; Roman Franiczek; Barbara Krzyżanowska; Łukasz Łaczmański; Paweł Migdał; Grażyna Gościniak
Journal:  Pathogens       Date:  2019-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.